These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31485921)

  • 1. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
    Schneider M; Potthoff AL; Keil VC; Güresir Á; Weller J; Borger V; Hamed M; Waha A; Vatter H; Güresir E; Herrlinger U; Schuss P
    J Neurooncol; 2019 Oct; 145(1):143-150. PubMed ID: 31485921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates.
    Schneider M; Ilic I; Potthoff AL; Hamed M; Schäfer N; Velten M; Güresir E; Herrlinger U; Borger V; Vatter H; Schuss P
    J Neurooncol; 2020 Sep; 149(3):455-461. PubMed ID: 32990861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
    Shah AH; Mahavadi A; Di L; Sanjurjo A; Eichberg DG; Borowy V; Figueroa J; Luther E; de la Fuente MI; Semonche A; Ivan ME; Komotar RJ
    J Neurooncol; 2020 Jul; 148(3):501-508. PubMed ID: 32627128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection.
    Borger V; Hamed M; Ilic I; Potthoff AL; Racz A; Schäfer N; Güresir E; Surges R; Herrlinger U; Vatter H; Schneider M; Schuss P
    J Neurooncol; 2021 Apr; 152(2):339-346. PubMed ID: 33554293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supratotal Resection of Glioblastoma: Better Survival Outcome than Gross Total Resection.
    Baik SH; Kim SY; Na YC; Cho JM
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobectomy versus gross total resection for glioblastoma multiforme: A systematic review and individual-participant data meta-analysis.
    Zheng Y; Saffari SE; Low DCY; Lin X; Ker JRX; Ang SYL; Ng WH; Wan KR
    J Clin Neurosci; 2023 Sep; 115():60-65. PubMed ID: 37487449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
    J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
    Jiang H; Cui Y; Liu X; Ren X; Lin S
    Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
    Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
    J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
    Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
    Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme.
    Glenn CA; Baker CM; Conner AK; Burks JD; Bonney PA; Briggs RG; Smitherman AD; Battiste JD; Sughrue ME
    World Neurosurg; 2018 Jun; 114():e747-e755. PubMed ID: 29555603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.